Safety Shot (NASDAQ:SHOT) Upgraded to “Hold” at Wall Street Zen

Safety Shot (NASDAQ:SHOT) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Saturday.

Safety Shot Trading Up 5.9%

Shares of SHOT opened at $0.65 on Friday. Safety Shot has a one year low of $0.23 and a one year high of $1.77. The company’s fifty day moving average price is $0.53 and its 200 day moving average price is $0.48.

Safety Shot (NASDAQ:SHOT) last announced its quarterly earnings data on Thursday, August 14th. The company reported ($0.03) EPS for the quarter. The firm had revenue of $0.45 million for the quarter.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Tyche Wealth Partners LLC raised its position in shares of Safety Shot by 142.9% during the second quarter. Tyche Wealth Partners LLC now owns 85,000 shares of the company’s stock valued at $28,000 after buying an additional 50,000 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Safety Shot during the first quarter valued at about $59,000. Jane Street Group LLC raised its position in shares of Safety Shot by 397.7% during the fourth quarter. Jane Street Group LLC now owns 102,267 shares of the company’s stock valued at $74,000 after buying an additional 81,720 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Safety Shot by 13.3% during the fourth quarter. Geode Capital Management LLC now owns 491,743 shares of the company’s stock valued at $354,000 after buying an additional 57,876 shares during the last quarter. Institutional investors and hedge funds own 12.55% of the company’s stock.

About Safety Shot

Safety Shot, Inc, a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen.